Literature DB >> 24078576

[Clinical and imaging features and genetic analysis of a case with adult-onset Krabbe disease].

Yu-wei Da1, Yun Li, Xin-qing Zhang, Jian-ping Jia.   

Abstract

OBJECTIVE: To investigate clinical and imaging features of a patient with adult-onset Krabbe disease and to detect the underlying genetic mutations.
METHODS: Clinical and cranial MRI features of the patient were analyzed. Pathogenesis, clinical manifestation, cranial MRI features and diagnostic criteria for the disease were discussed.
RESULTS: The patient had presented asymmetric limb weakness and difficulty in walking. Electromyography suggested peripheral nerve demyelination. Cranial MRI showed increased signal intensity in white matter with involvement of the corticospinal tracts. Screening of GALC gene mutation has found the patient to be heterozygous for T1685C (Ile562Thr) and homozygous for A1921G (Thr641Ala), both of which were considered to be polymorphisms. In addition, he was heterozygous for G136T (Asp46Tyr), which had not been described previously.
CONCLUSION: Clinical manifestations of adult-onset Krabbe disease may be atypical. Cranial MRI and galactocerebroside activity assay should be carried out for patients featuring chronic progressive corticospinal tract injury. An Asp46Tyr mutation probably underlies the disease in the current case.

Entities:  

Mesh:

Year:  2013        PMID: 24078576     DOI: 10.3760/cma.j.issn.1003-9406.2013.05.017

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  2 in total

1.  Two Cases of Female Chinese Adult-Onset Krabbe Disease with One Novel Mutation and a Review of Literature.

Authors:  Chengyi Zhang; Zheng Liu; Huiqing Dong
Journal:  J Mol Neurosci       Date:  2020-11-14       Impact factor: 3.444

2.  GALC mutations in Chinese patients with late-onset Krabbe disease: a case report.

Authors:  Shunzhi Zhuang; Lingen Kong; Caiming Li; Likun Chen; Tingting Zhang
Journal:  BMC Neurol       Date:  2019-06-11       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.